Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001354488-14-001026
Filing Date
2014-03-06
Accepted
2014-03-06 10:09:13
Documents
1
Period of Report
2014-03-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT issuerdirect_section16.html 4  
1 PRIMARY DOCUMENT issuerdirect_section16.xml 4 4344
  Complete submission text file 0001354488-14-001026.txt   5979
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 (816) 914-7027
DARA BioSciences, Inc. (Issuer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address
Drutz David (Reporting) CIK: 0001428764 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23776 | Film No.: 14671736